VANCOUVER, Feb. 17, 2017 /CNW/ - PUF Ventures Inc. (the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) confirms that there is no undisclosed material information pertaining to the Company's activities.
Management of the Company is currently visiting Germany and wishes to thank the Canabis Institut GMBH in Munich for hosting the Company's management and engaging in productive discussions about the future of cannabis in Germany.
About PUF Ventures Inc.
PUF Ventures Inc. is moving into the Bio Medical Cannabis sector by purchasing a 100 percent interest in AAA Heidelberg, a private Ontario company that has applied for an ACMPR license. Although the Company cannot guarantee nor estimate the timing for the issuance of a license to AAA Heidelberg, it is the Company's goal to become the next publicly traded Canadian company to be granted a new medical marijuana production license. VapeTronix, a subsidiary of the Company, is in the process of expanding its 1313 brand of electronic cigarettes, Marijuana Vape delivery devices, and associated technologies.
ON BEHALF OF THE BOARD OF DIRECTORS
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
Renseignements: Suite 804 - 750 West Pender Street, Vancouver, BC, V6C 2T7, T: (647) 241-4767, F: (604) 685-6905, W: www.pufventures.com